Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates

Journal: Nature

Published: 2020-07-22

DOI: 10.1038/s41586-020-2558-4

Affiliations: 14

Authors: 24

Go to article
Institutions Share
Centre de Recherche en Immunologie des Infections Virales et des Maladies Auto-immunes (IMVA), France 0.42
International Center for Infectiology Research (CIRI), France 0.14
Centres Nationaux de Référence des Virus des Infections Respiratoires (Dont la Grippe), Institut Pasteur, France 0.09
Infection, Antimicrobials, Modelling, Evolution (IAME), France 0.08
Laboratory Molecular Genetics of RNA Viruses (GMVR), France 0.07
Emerging Viral Diseases Unit (UVE), France 0.04
Institut Hospitalo-Universitaire en Maladies Infectieuses de Marseille (IHU Méditerranée Infection), France 0.04
Department of Global Health, Pasteur Institute, France 0.04
Emerging Viral Diseases (EPV), France 0.02
Assistance Publique-Hopitaux de Marseille (AP-HM), France 0.02
Lyon University Hospital (HCL), France 0.01
Mutualized Platform for Microbiology (P2M), Pasteur Institute, France 0.01
Pasteur International Bioresources Network (PIBnet), Pasteur Institute, France 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER